Health care stocks were lower Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.4%.
The iShares Biotechnology ETF (IBB) fell 1%.
In corporate news, Spingworks Therapeutics (SWTX) shares jumped over 36%. The company is in advanced talks to be acquired by Merck KGaA, Reuters reported.
Axsome Therapeutics (AXSM) shares rose 21% after the firm said it agreed to a settlement deal with Teva (TEVA) to resolve patent litigation over its Auvelity product. Teva was down 0.8%.
Pliant Therapeutics (PLRX) shares fell 59% after the firm paused enrollment and dosing in a phase 2b trial of bexotegrast in idiopathic pulmonary fibrosis patients. Several analysts downgraded the stock following the announcement.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。